| abstract |
The invention relates to the use of a therapeutic biological molecule for the prevention and treatment of multiple sclerosis disease or for relieving the symptoms caused by this disease. Accordingly, the biological molecule, which is mentioned in the invention with no therapeutic, side effects and toxic effects, acts by significantly and statistically reducing the number of lymphocytes infiltrating the central nervous system, T cell subset and especially, IL-17, IL-22 and GM-CSF producing cells together with IFN-g, IFN-g and IL-17A. |